Bioinformatics Services Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 3.94 Bn

Forecast Year, 2035

USD 15.27 Bn

CAGR, 2026 - 2035

14.51%

Report Coverage

Global

What is the Bioinformatics Services Market Size?

The global bioinformatics services market size is calculated at USD 3.94 billion in 2025 and is predicted to increase from USD 4.52 billion in 2026 to approximately USD 15.27 billion by 2035, expanding at a CAGR of 14.51% from 2026 to 2035. The bioinformatics services market is driven by increased funding and investment, growing adoption of cloud-based solutions, and the integration of artificial intelligence and machine learning for biological data processing and analysis.

Market Highlights

• North America led the bioinformatics services market with around 48.4% of the market share in 2025.
• Asia Pacific is estimated to expand the fastest CAGR between 2026 and 2035
• By type, the sequencing services segment captured the 47.3% of market share in 2025.
• By type, the data analysis services segment is expected to grow at a 11.6% CAGR from 2026 to 2035
• By application, the genomics segment held a major market share of 56.4% in 2025.
• By application, the proteomics segment is growing at a CAGR of 12.1% from 2026 to 2035
• By deployment mode, the cloud-based segment held major market share of 61.4% in 2025.
• By deployment mode, the hybrid model segment is growing at a strong CAGR of 11.5% between 2026 to 2035
• By end-user, the pharmaceutical & biotechnology companies segment captured more than 48.8% of market share in 2025.
• By end-user, the hospitals & clinical laboratories segment is growing at a strong CAGR of 11.7% from 2026 to 2035

Factors Contributing to Market Growth of Bioinformatics Services

The bioinformatics services market is experiencing robust growth, driven by increased demand for data-driven research in genomics , proteomics , and precision medicine . Bioinformatics services use computational tools and software to process, analyze, and interpret biological data, thereby facilitating advancements in drug discovery , molecular diagnostics , and personalized medicine.

They are widely utilized by pharmaceutical companies, biotechnology firms, academic institutions, and healthcare organizations. Market growth is driven by advancements in next-generation sequencing (NGS), AI-driven analytics, personalized medicine, and rising demand for outsourced bioinformatics expertise and cloud-based computational infrastructure.

AI is Changing the Future of the Bioinformatics Services Industry

AI is transforming bioinformatics services through faster, smarter analysis of complex biological data. Innovations in deep learning and neural networks are improving accuracy in genome sequencing, protein structure predictions, and the integration of multi-omics data. An increasing number of AI models are predicting disease susceptibility and facilitating drug discovery and personalized medicine through data-driven insights.

In April 2025, Signios Biosciences, a science-first biotechnology company at the leader of multiomics and AI-powered bioinformatics, announced the Launch of an AI-driven bioinformatics and advanced multiomics platform to power the future of precision medicine and drug discovery.

Bioinformatics services use machine learning to automate previously tedious or repetitive tasks, extracting useful or meaningful biological patterns that were difficult or impossible to identify. Educational initiatives and industry collaborations are helping to broaden the scope for the use of AI for molecular diagnostics and genetic studies, thus narrowing the gap between data science and life sciences. As AI systems grow, bioinformatics services will play an increasingly important role in developing personalized and predictive healthcare innovations.

Bioinformatics Services Market Outlook

[[market_outlook]]

Market Scope

Bioinformatics Services Market Segment Insights

[[segment_insights]]

Bioinformatics Services Market Regional Insights

[[regional_insights]]

Overview of Global Government-Funded Bioinformatics Institutes

Bioinformatics Services Market Value Chain

Bioinformatics Services Market Companies

[[market_company]]

Other Players in the Market for Bioinformatics Services

• QIAGEN N.V .: QIAGEN provides comprehensive bioinformatics software and services through its CLC Genomics platform, designed to streamline genomic data analysis and reduce computational bottlenecks. The company's solutions support next-generation sequencing (NGS), RNA-seq, and variant analysis workflows for researchers in genomics, diagnostics, and drug discovery.
• PerkinElmer , Inc. – PerkinElmer offers advanced bioinformatics and informatics solutions for managing and interpreting large-scale biological data. Its software platforms integrate multi-omics data processing, visualization, and predictive modeling, supporting applications in precision medicine, diagnostics, and life sciences research.
• DNAnexus, Inc: DNAnexus provides a secure, cloud-based bioinformatics platform for genomic data analysis, storage, and sharing. The company's platform supports diverse data types, including DNA, RNA, and proteomics, enabling scalable, collaborative research in clinical genomics and population health initiatives.
• BGI Genomics Co., Ltd: BGI Genomics delivers next-generation sequencing and bioinformatics services leveraging its proprietary DNBse technology. The company provides genomic, transcriptomic, and epigenetic analysis solutions for applications in human health, agriculture, and biodiversity research.
• Eurofins Scientific: Eurofins Genomics offers a wide range of sequencing and bioinformatics services, including NGS, Sanger sequencing, and oligonucleotide synthesis. As one of Europe's first providers of NGS using the Roche/454 GS20 system, Eurofins continues to deliver high-quality data interpretation and analysis support for research institutions and biopharma clients.
• Fios Genomics Ltd.: Fios Genomics provides bioinformatics data analysis services for pharmaceutical, biotechnology, and academic clients. The company specializes in integrating genomics, transcriptomics, proteomics, and metabolomics data, supporting drug discovery, preclinical, and clinical development projects.
• Seven Bridges Genomics (Velsera): Seven Bridges, now part of Velsera, offers a robust cloud-based bioinformatics platform integrating tools such as the GRA Suite for next-generation sequencing (NGS) analysis. The company supports end-to-end data management, analysis, and collaboration for genomics research and clinical data science.
• Biomax Informatics AG: Biomax Informatics develops knowledge management and bioinformatics software for data integration and systems biology. Its BioXM platform helps life science companies and research institutions manage complex biological data and derive actionable insights for R&D.
• GENEWIZ (Azenta Life Sciences): GENEWIZ, now operating under Azenta Life Sciences, provides sequencing, gene synthesis, and bioinformatics services for genomics research. The company's bioinformatics solutions include data analysis pipelines for NGS, single-cell sequencing, and metagenomics applications.
• Macrogen, Inc: Macrogen offers a full range of genomic sequencing and bioinformatics services, including human whole-genome sequencing, transcriptomics, and clinical genomics. The company's bioinformatics division provides data interpretation and reporting for precision medicine and genetic research.
• Pine Biotech, Inc.: Pine Biotech provides bioinformatics education and analysis platforms such as the T-BioInfo portal, which supports transcriptomics, metagenomics, and machine learning-based data analysis. The company focuses on democratizing bioinformatics tools for researchers and educators worldwide.
• Dassault Systemes (BIOVIA): BIOVIA, a division of Dassault Systemes, offers informatics and bioinformatics solutions that integrate life sciences data modeling, molecular simulation, and research workflow management. Its platforms enable data-driven decision-making in biopharmaceutical R&D and precision medicine.
• Genedata AG: Genedata develops enterprise bioinformatics software for automating and scaling omics data analysis. Its solutions, such as Genedata Profiler and Genedata Screener, support biopharmaceutical research, biomarker discovery, and translational medicine programs.

Exclusive Insights

From a market research perspective, the bioinformatics services market is on a multi-year growth trajectory driven by declining sequencing costs, increased adoption of bioinformatics-as-a-service in the cloud, and increased outsourcing by pharma and clinical organizations. Advancements in AI, particularly protein language models and ML-driven variant interpretation, should increase throughput, clinical-grade reporting, and modular subscription offerings.

Commercial opportunities will likely include managed clinical pipelines, analytics for compliant companion diagnostics, and collaborations with sequencing clinics or CROs. Principal risk factors include data privacy and consent frameworks, a lack of standardization and interoperability, an insufficient number of skilled talent, and reproducibility. Firms that invest in validated pipelines, compliance and regulatory assessments, domain experts, and geographic expansion options will likely accrue asymmetrical market value.

Bioinformatics Services MarketSegments Covered in the Report

[[segment_covered]]